Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Di | INTEGRUM AB: Integrum expands its product offering into the Israeli market | 1 | Cision News | ||
19.03. | INTEGRUM AB: Health economic study shows positive outcome using Integrum's OPRA Implant System over socket prostheses in transfemoral amputees | 2 | Cision News | ||
29.02. | Integrum AB: A new record revenue quarter with 61% growth | 321 | PR Newswire | MÖLNDAL, Sweden, Feb. 29, 2024 /PRNewswire/ --
THIRD QUARTER 2023/24 (NOV - JAN)
Net sales amounts to 30.1 (18.7) MSEK, which is an increase of 61% compared with the corresponding period last... ► Artikel lesen | |
23.02. | Integrum AB: Invitation to the Third Quarter 2023/24 Results Presentation | 1 | Cision News | ||
31.01. | INTEGRUM AB: Integrum has sold and delivered OPRA Implant Systems to a value of SEK 3.5 million to Center of Excellence in Ukraine | 2 | Cision News | ||
15.12.23 | INTEGRUM AB: Integrum's MDR certification is completed for the OPRA Implant System | 3 | Cision News | ||
04.12.23 | Record sales and profitability: Integrum AB | 312 | PR Newswire | MÖLNDAL, Sweden, Dec. 4, 2023 /PRNewswire/ --
SECOND QUARTER 2023/24 (MAY - JULY)
Net sales amounted to SEK 27.6 (20.2) million, which is an increase of 36% compared with the corresponding... ► Artikel lesen | |
04.12.23 | INTEGRUM AB: Record sales and profitability | 1 | Cision News | ||
30.11.23 | Integrum AB changes Certified Adviser to Carnegie Investment Bank AB (publ) | 1 | Cision News | ||
28.11.23 | Integrum AB: Invitation to the Second Quarter 2023/24 Results Presentation | 1 | Cision News | ||
13.11.23 | INTEGRUM AB: Integrum plans to submit a PMA application to the FDA for the use of OPRA in transhumeral amputations based on existing clinical data | 1 | Cision News | ||
10.11.23 | INTEGRUM AB: Correction missing MAR reference: Integrum publishes preliminary revenue, result and and cash flow figures for Q2, 2023 | 1 | Cision News | ||
10.11.23 | INTEGRUM AB: Clinical study of Integrum's OPRA Implant System on below-knee amputations will include up to 30 patients and is fully funded by the Department of Defense | 1 | Cision News | ||
09.11.23 | INTEGRUM AB: Integrum publishes preliminary revenue, result and and cash flow figures for Q2, 2023 | 2 | Cision News | ||
30.10.23 | INTEGRUM AB: Integrum's OPRA Implant System gets FDA approval for clinical study on below-knee amputations | 1 | Cision News | ||
27.10.23 | INTEGRUM AB: Integrum moves into Turkey | 2 | Cision News | ||
12.10.23 | INTEGRUM AB: Integrum announces the world's first long-term integrated bionic hand enriched with motor and sensory AI | 3 | Cision News | ||
10.10.23 | INTEGRUM AB: Integrum receives a Unitary Patent for Neuromotus in the EU | 2 | Cision News | ||
10.10.23 | INTEGRUM AB: Integrum welcomes Scott Flora as full board member | 1 | Cision News | ||
06.09.23 | Integrum ESG's Transparent Signal Has Been Added to CSRHub | 354 | ACCESSWIRE | NORTHAMPTON, MA / ACCESSWIRE / September 6, 2023 / CSRHub Transparent ESG Data PartnershipWe recently added Integrum ESG's data set to CSRHub. Nearly 900 sources of ESG opinion now contribute to our... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
MEDTRONIC | 80,48 | +0,45 % | Dividendenbekanntmachungen (21.03.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AXFOOD AB SE0006993770 4,25 SEK 0,3746 EUR BANCO DE CHILE ADR US0595201064 1,6924 USD 1,5481 EUR BEAZLEY PLC GB00BYQ0JC66 0,142... ► Artikel lesen | |
INTUITIVE SURGICAL | 374,75 | +1,65 % | Intuitive Surgical: Neues System zugelassen | Der Hersteller des minimal-invasiven Medizinrobotics-Systems da Vinci verzeichnet deutlich steigende operative Zahlen. Im vergangenen Jahr legte der Umsatz um 14 % auf 7,1 Mrd. $ zu. Dieses Wachstumstempo... ► Artikel lesen | |
STRATEC | 37,650 | -11,20 % | Stratec bestätigt Prognose und senkt Dividende für 2023 | Stratec-Aktionäre sollen für das Geschäftsjahr 2023 eine Dividende in Höhe von 0,55 Euro je Aktie erhalten. Einen entsprechenden Ausschüttungsvorschlag wird die Gesellschaft ihren Anteilseignern auf... ► Artikel lesen | |
EUROFINS SCIENTIFIC | 58,28 | +2,57 % | Eurofins: Purchases of Own Shares from the 18th to the 22th of March 2024 | Regulatory News:
Eurofins (Paris:ERF):
Name of the Issuer Identity code of the Issuer Day of the transaction Identity code of the financial instrument Total... ► Artikel lesen | |
GERATHERM MEDICAL | 4,340 | 0,00 % | Geratherm Medical AG: Geratherm meldet Kurzarbeit an; Kursziel gesenkt; mwb research bekräftigt KAUFEN | Geratherm hat angekündigt, im Werk Geratal Kurzarbeit zu beantragen, weil der Absatz von Fieberthermometern aufgrund des milden Winters unter Plan lag. Der Anteil der Fieberthermometer am Gesamtumsatz... ► Artikel lesen | |
SYNLAB | 10,930 | +0,37 % | Ihre wichtigsten Termine: Alle Analysten Augen auf: Synlab, Adesso, Kingfisher, Hypoport, Ströer und MTU | Gut geplant in den Tag. Mit dem w:o-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Unternehmenstermine 07:00 Uhr, Deutschland: Ströer... ► Artikel lesen | |
ALIGN TECHNOLOGY | 303,85 | +0,28 % | Here's Why You Should Buy Align Technology (ALGN) Stock Now | ||
HIMS & HERS HEALTH | 14,400 | -0,69 % | Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results | SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS), the leading health and wellness platform, today announced financial results for the fourth... ► Artikel lesen | |
PAUL HARTMANN | 214,00 | +0,47 % | Aktuell zu Ihren Aktien: Funkwerk, Paul Hartmann | Seit rund zwei Jahren ist mit der früher so gut laufenden Funkwerk-Aktie an der Börse nicht mehr viel los. Angesichts der Kursflaute wurde der Titel des in den Bereichen Funksysteme für den Bahnverkehr... ► Artikel lesen | |
INMODE | 19,390 | -1,12 % | InMode LTD: InMode Reports Fourth Quarter and Full Year 2023 Financial Results; Quarterly Revenue of $126.8M and Record Full Year Revenue of $492M | YOKNEAM, Israel, Feb. 13, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results... ► Artikel lesen | |
INVITAE | 0,110 | 0,00 % | Invitae Corporation: Invitae Reports Estimated Unaudited Fourth Quarter and Full Year 2023 Financial Results | SAN FRANCISCO, March 6, 2024 /PRNewswire/ -- Invitae (OTC: NVTA), a leading medical genetics company, today announced estimated unaudited fourth quarter and full year 2023 revenue, gross profit... ► Artikel lesen | |
BOSTON SCIENTIFIC | 63,38 | -0,06 % | Scivita Medical Expands Collaboration with Boston Scientific | SUZHOU, China, March 26, 2024 /PRNewswire/ -- Recently, Scivita Medical Technology Co., Ltd. ("Scivita Medical") and Boston Scientific Corporation (NYSE: BSX), a leading global medical technology... ► Artikel lesen | |
RESMED | 181,40 | 0,00 % | Here's why I think the Resmed share price should be 18% higher | ||
MCKESSON | 500,00 | +0,40 % | Rite Aid inks bankruptcy deal with stakeholders including McKesson | ||
ZIMMER BIOMET | 122,15 | -0,29 % | Dividendenbekanntmachungen (27.03.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACADIA REALTY TRUST US0042391096 0,18 USD 0,1661 EUR ACADIAN TIMBER CORP CA0042721005 0,29 CAD 0,197 EUR ACME UNITED CORPORATION US0048161048 0... ► Artikel lesen |